DLD Asset Management’s Envoy Medical COCH Stock Holding History

DLD Asset Management’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,169,918	Closed	-$11.8M	–	127
2022 Q4	$11.8M	Buy	1,169,918 +5,083	+0.4%	+$50.5K	0.99%	34
2022 Q3	$11.4M	Hold	1,164,835	–	–	0.89%	35
2022 Q2	$11.4M	Hold	1,164,835	–	–	0.81%	39
2022 Q1	$11.4M	Hold	1,164,835	–	–	0.72%	35
2021 Q4	$11.3M	Sell	1,164,835 -10,165	-0.9%	-$99.1K	0.61%	37
2021 Q3	$11.4M	Hold	1,175,000	–	–	0.83%	30
2021 Q2	$11.4M	Buy	+1,175,000	New	+$11.4M	0.79%	33

Other funds holding COCH

AMC

Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

DLD Asset Management's COCH Position: Q1 2023 in Review

DLD Asset Management sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 1,169,918 shares — an estimated $11.8M sold.

DLD Asset Management first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $11.8M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

DLD Asset Management reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
DLD Asset Management sold 1,169,918 Envoy Medical shares in Q1 2023, an estimated $11.8M.
DLD Asset Management first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
DLD Asset Management's Envoy Medical position peaked at $11.8M in Q4 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on DLD Asset Management's 13F filing for Q1 2023, filed 15 May 2023.